Welcome! 

The Blood and Marrow Stem Cell Transplantation/Hematologic Malignancies Program provides state-of-the-art care for patients with hematologic malignancies (leukemia, lymphoma, myeloma, and myelodysplasia).  Our mission is to provide the best possible care to patients with cancers of the blood, bone marrow and lymph nodes, and to carry out laboratory and clinical research in order to discover and develop new and better treatments for these diseases.

Our Program includes:

• Accreditation granted by the Foundation for the Accreditation of Cellular Therapy (FACT).
  
• A highly experienced team of physicians, nurses and ancillary staff.  The team physicians, who trained at leading institutions including Harvard, Fred Hutchinson Cancer Research Center in Seattle, Northwestern University and UCLA, are experts in all aspects of hematologic malignancies and stem cell transplantation.  Patients are cared for by a team approach that provides comprehensive and individualized care.
  
• Expert diagnosis.  The UT Southwestern hematopathology laboratory is a recognized world leader.
  
• All treatment approaches, including chemotherapy, radiation, stem cell transplantation, immunotherapy, radioimmunotherapy, and experimental therapy.
  
• Excellent clinical results with outcomes superior to national norms in several areas.
  
• Recognized leadership in laboratory and clinical research.